https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-882009-01-01 00:00:002019-02-15 08:32:29New therapeutic strategies in acute lymphoblastic leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-482009-01-01 00:00:002019-02-15 08:32:29Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-672008-09-20 00:00:002019-02-15 08:45:28The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):521-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):521-412008-09-01 00:00:002019-02-15 08:32:30Dendritic cell vaccines in acute leukaemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-01 / Am. J. Hematol. 2008 Apr;83(4):315-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-01 / Am. J. Hematol. 2008 Apr;83(4):315-72008-04-01 00:00:002019-02-15 08:32:32Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-39
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-392008-01-22 00:00:002019-02-15 08:32:33Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-15 / Transfusion 2008 May;48(5):861-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-15 / Transfusion 2008 May;48(5):861-702008-01-15 00:00:002019-02-15 08:32:31Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Transfusion 2007 Sep;47(9):1588-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Transfusion 2007 Sep;47(9):1588-942007-09-01 00:00:002019-02-15 08:32:34Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / Expert Rev Anticancer Ther 2007 Mar;7(3):275-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / Expert Rev Anticancer Ther 2007 Mar;7(3):275-832007-03-01 00:00:002019-02-15 08:37:33Dendritic cell vaccines for leukemia patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-27 / Biomed. Pharmacother. 2007 Jul;61(6):306-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-27 / Biomed. Pharmacother. 2007 Jul;61(6):306-142007-02-27 00:00:002019-02-15 08:32:36Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia
